Effect of Different Left Lateral Table Tilt for Elective Cesarean Delivery Under Spinal Anesthesia

June 9, 2021 updated by: Chao Xu, Xuzhou Medical University

Effect of Different Left Lateral Table Tilt on Neonatal Acid-base Status and Maternal Hemodynamics for Elective Cesarean Delivery Under Spinal Anesthesia

The recommended position of the mother under caesarean section after spinal anesthesia is 15 degrees left. However, recent research has challenged the basic principles and practicality of the left-turn 15 degree position. Higuchi et al used nuclear magnetic imaging to directly prove that in the supine position, the position of the full-left 30 degrees of the full-term pregnancy of the full-term pregnancy relieved the inferior vena cava compression and the left-angle of 15 degrees did not. Therefore, there are more and more controversies about the choice of cesarean section position. This experiment aims to explore effects of different positions (15 degrees left, 30 degrees left and supine) for elective cesarean section on lumbar anesthesia for fetal acid-base balance and maternal Hemodynamic.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

When the pregnant woman in the third trimester is in the supine position, the enlarged uterus may oppress the inferior vena cava, thereby reducing the amount of blood and heart output of the pregnant woman. This affects the mother mainly, such as dizziness, nausea and vomiting, chills, and severe irritability,difficulty breathing or even cardiac arrest, the impact on the fetus is mainly the reduction of blood flow in the placenta, affecting the blood exchange of the uterus placenta, causing neonatal respiratory distress, acidosis and even death. The recommended position of the mother under caesarean section after spinal anesthesia is 15 degrees left. However, recent research has challenged the basic principles and practicality of the left-turn 15 degree position. Higuchi et al used nuclear magnetic imaging to directly prove that in the supine position, the position of the full-left 30 degrees of the full-term pregnancy of the full-term pregnancy relieved the inferior vena cava compression and the left-angle of 15 degrees did not. Therefore, there are more and more controversies about the choice of cesarean section position. This experiment aims to explore effects of different positions (15 degrees left, 30 degrees left and supine) for elective cesarean section on lumbar anesthesia for fetal acid-base balance and maternal Hemodynamic.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Xuzhou, Jiangsu, China, 221000
        • Liu Tian yu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Singleton pregnancy at term via elective cesarean section
  • Height from 150 cm to 180 cm
  • American Society of Anesthesiologists (ASA) grade from I to II grade
  • BMI(Body Mass Index,mearsured weight divided by height squared)less than 35 kg/m2.

Exclusion Criteria:

  • Transverse lie
  • Fetal macrosomia
  • Uterine abnormalities (e.g., large fibroids, bicornuate uterus)
  • Polyhydramnios
  • Ruptured membranes
  • Oligohydramnios
  • Intrauterine growth restriction
  • Gestational or nongestational hypertension, diabetes, eclampsia
  • Hypertensive disorder or any condition associated with autonomic neuropathy (e.g., diabetes mellitus for more than 10 yr), with renal failure
  • Have contraindications for spinal anesthesia(Such as low back infection, spinal deformity, etc.)
  • Participants refused to sign informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Supine group
After the patient completes the spinal anesthesia, the cesarean section is completed in the supine position.
After the spinal anesthesia is completed, the wedge sponge is placed between the patient's pelvis and ribs and the wedge is removed before the skin is cut.
ACTIVE_COMPARATOR: 15° group
After the patient completed the spinal anesthesia, the preoperative preparation (about 10 minutes) was completed with a left tilt of 15°, and the cesarean section was completed using the supine position after the skin was cut.
After the spinal anesthesia is completed, the wedge sponge is placed between the patient's pelvis and ribs and the wedge is removed before the skin is cut.
ACTIVE_COMPARATOR: 30° group
After the patient completed the spinal anesthesia, the preoperative preparation (about 10 minutes) was completed with a left tilt of 30°, and the cesarean section was completed using the supine position after the skin was cut.
After the spinal anesthesia is completed, the wedge sponge is placed between the patient's pelvis and ribs and the wedge is removed before the skin is cut.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Umbilical artery blood pH
Time Frame: Immediately after delivery
Use a blood gas analyzer to measure
Immediately after delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Other UA and UV blood gas analysis values(pH, base excess, lactate , Umbilical artery blood PaCO2
Time Frame: Immediately after delivery
Use a blood gas analyzer to measure, PaCO2 in mmHg.
Immediately after delivery
Fetal Apgar score (1 minute after birth) And 5 minutes
Time Frame: One minute and five minutes after the baby is delivered
Measured by Apgar score.The Apgar scoring system is divided into five categories(muscle tone,heart rate,grimace and respiration) Appearance. Each category receives a score of 0 to 2 points. At most, a child will receive an overall score of 10(The higher the score, the better the child's condition).
One minute and five minutes after the baby is delivered
The incidence of nausea in pregnant women
Time Frame: Intraoperative
Anesthesiologist observes combined patient dictation.
Intraoperative
The incidence of vomiting in pregnant women
Time Frame: Intraoperative
Anesthesiologist observes combined patient dictation
Intraoperative
The incidence of hypotension in pregnant women
Time Frame: Intraoperative
The increase of SBP <20% baseline SBP or SBP < 90/60mmHg
Intraoperative
The incidence of hypertension in pregnant women
Time Frame: Intraoperative
The increase of SBP >20% baseline SBP
Intraoperative
The incidence of bradycardia in pregnant women
Time Frame: Intraoperative
Heart rate less than 60 times per minute
Intraoperative
One min (T1), 3 min (T2), 5 min (T3), 7 min (T4), 9 min (T5), 11 min (T6), 13 min (T7) and 15 min (T8) blood pressure after subarachnoid injection (completion of the subarachnoid injection was defined as 0 time point)
Time Frame: Intraoperative
Measured by a sphygmomanometer.Systolic and diastolic blood pressure will be measured every minute during the study.
Intraoperative
One min (T1), 3 min (T2), 5 min (T3), 7 min (T4), 9 min (T5), 11 min (T6), 13 min (T7) and 15 min (T8) heart rate after subarachnoid injection (completion of the subarachnoid injection was defined as 0 time point)
Time Frame: Intraoperative
Obtained by ECG measurement
Intraoperative
Dosage of phenylephrine during surgery
Time Frame: Intraoperative
Used by an anesthesiologist based on the patient's blood pressure and heart rate.If the patient's blood pressure is less than 80% of the baseline level or less than 90/60 mmHg and the heart rate is greater than 60 times per minute, the patient is given 4 ug of phenylephrine.
Intraoperative
Dosage of ephedrine during surgery
Time Frame: Intraoperative
Used by an anesthesiologist based on the patient's blood pressure and heart rate.If the patient's blood pressure is less than 80% of the baseline level or less than 90/60 mmHg and the heart rate is smaller than 60 times per minute, the patient is given 6 mg of ephedrine.
Intraoperative
Dosage of atropine during surgery
Time Frame: Intraoperative
Used by an anesthesiologist based on the patient's blood pressure and heart rate.If the patient's heart rate is smaller than 60 times per minute, and blood pressure is more than 80% of the baseline level and more than 90/60 mmHg, the patient is given 0.5 mg of atropine.
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2019

Primary Completion (ACTUAL)

January 31, 2020

Study Completion (ACTUAL)

February 10, 2020

Study Registration Dates

First Submitted

August 30, 2019

First Submitted That Met QC Criteria

September 6, 2019

First Posted (ACTUAL)

September 10, 2019

Study Record Updates

Last Update Posted (ACTUAL)

June 14, 2021

Last Update Submitted That Met QC Criteria

June 9, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • XYFY2019-KL126-02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD will be available when this trial is finished and the article have been published

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Anesthesia

Clinical Trials on 15° and 30° wedge sponges

Subscribe